Affimed N V Asset Turnover Ratio (AFMD), as of fourth quarter 2023, current and historic results, rankings and more - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Affimed N v   (NASDAQ: AFMD)
 

Affimed N V Asset Turnover Ratio

Quarterly Results, Trends, Rankings, Statistics

Affimed N V 's asset turnover ratio, the ratio that measures the ability of Affimed N V 's assets to generate revenue, sequentially decreased to 0.1 in the fourth quarter (Dec 31 2023), which does not come as a surprise, as the Affimed N V continue to experience difficult business climate.

Within sector 32 more businesses have achieved higher asset turnover ratio. While ranking the asset turnover ratio, among all other companies, it is fair to say, that the company's position has deteriorated in the fourth quarter 2023 compared to the preceding quarter from 0 to 766.

Asset Turnover Ratio Definition


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

AFMD Asset Turnover Ratio (Dec 31 2023)
IV. Quarter		 0
III. Quarter		 0
II. Quarter		 0
I. Quarter		 (Dec 31 2022)
IV. Quarter
Y / Y Asset Change -51.55 % -51.55 % -51.55 % -51.55 % -10.94 %
Y / Y Revenue Change -79.99 % - -80.54 % - 2.45 %
Asset Turnover Ratio (TTM) 0.1 - 0.29 - 0.24
AFMD's Total Ranking # 766 # 0 # 0 # 0 # 3470
Seq. Asset Change 0 % 0 % 0 % -51.55 % 0 %
Seq. Revenue Change - - - - -



Asset Turnover Ratio Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 33
Healthcare Sector # 71
Overall Market # 766

Asset Turnover Ratio Statistics
High Average Low
115.28 76.41 17.87
(Dec 31 2020)   (Dec 31 2023)




AFMD Company Profile • Back to AFMD Efficiency Comparisons • Compare AFMD Asset Turnover Ratio to its Competitors



Companies with similar Asset Turnover Ratio for the quarter ending Dec 31 2023, within Healthcare Sector Asset Turnover Ratio Revenues for 12 Months ending Dec 31 2023 Assets at quarter ending Dec 31 2023
Innoviva Inc   0.27 $ 315.267  Millions$ 1,169.905  Millions
Alpha Teknova Inc   0.27 $ 36.296  Millions$ 135.135  Millions
Bioaffinity Technologies Inc   0.27 $ 2.532  Millions$ 9.437  Millions
Entrada Therapeutics Inc   0.27 $ 129.013  Millions$ 480.944  Millions
Ionis Pharmaceuticals Inc   0.27 $ 787.647  Millions$ 2,945.099  Millions
Telesis Bio Inc   0.27 $ 25.178  Millions$ 94.782  Millions
Scisparc Ltd  0.27 $ 2.879  Millions$ 10.860  Millions
Schrodinger Inc   0.26 $ 215.692  Millions$ 819.361  Millions
Veru Inc   0.26 $ 15.199  Millions$ 58.130  Millions
Quantum Biopharma Ltd   0.26 $ 4.556  Millions$ 17.475  Millions
Travere Therapeutics Inc   0.25 $ 198.844  Millions$ 791.606  Millions
Zai Lab Limited  0.24 $ 266.719  Millions$ 1,089.109  Millions
Repligen Corp  0.24 $ 632.362  Millions$ 2,614.729  Millions
Nutriband Inc   0.24 $ 2.085  Millions$ 8.647  Millions
Revvity Inc  0.24 $ 3,305.275  Millions$ 13,848.617  Millions
Dynavax Technologies Corporation  0.24 $ 231.284  Millions$ 969.096  Millions
Invo Fertility Inc   0.24 $ 3.021  Millions$ 12.693  Millions
Eiger Biopharmaceuticals Inc   0.24 $ 15.773  Millions$ 66.517  Millions
Adaptive Biotechnologies Corporation  0.23 $ 170.276  Millions$ 733.705  Millions
Retractable Technologies Inc  0.23 $ 42.857  Millions$ 185.403  Millions
Cryoport inc   0.23 $ 233.255  Millions$ 1,009.290  Millions
Bioadaptives Inc   0.23 $ 0.029  Millions$ 0.124  Millions
Rhythm Pharmaceuticals Inc   0.23 $ 77.428  Millions$ 335.641  Millions
Accelerate Diagnostics Inc   0.23 $ 9.745  Millions$ 42.893  Millions
Theralink Technologies Inc   0.23 $ 0.511  Millions$ 2.251  Millions
Arrowhead Pharmaceuticals Inc   0.23 $ 181.740  Millions$ 804.567  Millions
Blueprint Medicines Corporation  0.22 $ 249.380  Millions$ 1,120.341  Millions
Nurix Therapeutics Inc   0.22 $ 76.987  Millions$ 346.143  Millions
Neurometrix Inc   0.22 $ 4.947  Millions$ 22.274  Millions
Poseida Therapeutics Inc   0.22 $ 64.703  Millions$ 292.743  Millions



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.